CDNS Cadence Design Systems
Superb EDA franchise, faster growth now, but $309 still prices non-GAAP perfection; patience pays.
The story
Cadence is one half of an entrenched EDA duopoly with Synopsys, selling mission-critical chip design software, IP and hardware emulation/verification systems on sticky multi-year subscriptions. AI accelerators, custom silicon, chiplets and the growing complexity of advanced nodes keep design spend rising, and Cadence is extending into system analysis and simulation. It is a mature-growth franchise with a long reinvestment runway, but GAAP margins already carry heavy stock-based compensation, and the stock prices in near-perfect execution.
TTM revenue grew about 16% to $6.13B, ahead of my prior 13%, so I moved Y1 growth to 14%. The GAAP margin target goes to 38% (from 36%) on operating leverage, still net of SBC. I raised sales-to-capital from 1.0 to 1.2 because organic reinvestment is light (capex of $0.21B is below D&A of $0.39B) and the reported 0.77 is inflated by acquired goodwill. Even so, value stays far below price: the market is paying for non-GAAP margins and growth above 15% for a decade.
Value drivers
| Revenue growth (Y1) | 14.0% |
| Terminal growth | 4.0% |
| Forecast horizon | 12y |
| Target operating margin | 38.0% |
| Years to target margin | 5 |
| Sales-to-capital | 1.20 |
| Beta | 1.15 |
| Failure probability | 1.0% |
| Cost of capital (WACC) | 10.1% |
| Terminal WACC | 9.5% |
Valuation bridge
| PV of explicit FCFF | 15.20B |
| PV of terminal value | 20.97B |
| Equity value | 36.32B |
| ÷ shares → per share | $132.37 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 6.99B | 14.0% | 33.3% | 1.69B | 715.41M | 978.08M | 888.03M |
| 2 | 7.91B | 13.1% | 34.4% | 1.98B | 762.61M | 1.22B | 1.01B |
| 3 | 8.87B | 12.2% | 35.6% | 2.30B | 802.55M | 1.50B | 1.12B |
| 4 | 9.87B | 11.3% | 36.8% | 2.65B | 833.13M | 1.81B | 1.23B |
| 5 | 10.89B | 10.4% | 38.0% | 3.02B | 852.28M | 2.16B | 1.33B |
| 6 | 11.92B | 9.5% | 38.0% | 3.30B | 858.10M | 2.44B | 1.37B |
| 7 | 12.94B | 8.5% | 38.0% | 3.58B | 848.92M | 2.73B | 1.39B |
| 8 | 13.93B | 7.6% | 38.0% | 3.86B | 823.44M | 3.03B | 1.40B |
| 9 | 14.86B | 6.7% | 38.0% | 4.12B | 780.80M | 3.33B | 1.40B |
| 10 | 15.73B | 5.8% | 38.0% | 4.35B | 720.72M | 3.63B | 1.38B |
| 11 | 16.50B | 4.9% | 38.0% | 4.57B | 643.49M | 3.93B | 1.36B |
| 12 | 17.16B | 4.0% | 38.0% | 4.75B | 550.06M | 4.20B | 1.32B |
Key risks
- Semiconductor capex or design-start slowdown, or an AI-chip spending digestion phase, hitting hardware and IP bookings
- US export controls limiting China revenue (roughly 12-15% of sales)
- Hyperscaler in-house tooling, Synopsys-Ansys competitive bundling, or acquisition missteps diluting returns
Catalysts
- Hardware system (Palladium/Protium) refresh cycles and AI-driven design automation lifting ASPs and backlog
- Margin expansion toward 40%+ GAAP as SBC growth slows relative to revenue